ARCHIVES

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997

Funding Opportunities Listed.

January 14, 2005

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014